Corbus Pharmaceuticals
Home :: Corbus Pharmaceuticals Holdings, Inc. (CRBP).
Launch date
Employees
Market cap
CAD847m
Enterprise valuation
CAD667m (Public information from Sep 2024)
Share price
$51.7 CRBP
Company register number 11195935
Norwood Illinois (HQ)
Financials
Estimates*
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 4.8m | 36.1m | 3.9m | <1m | - | - | 2.0m |
| % growth | 98 % | 650 % | (89 %) | (78 %) | - | - | - |
| EBITDA | (56.3m) | (76.9m) | (122m) | (56.3m) | (29.5m) | (44.4m) | - |
| % EBITDA margin | (1167 %) | (213 %) | (3101 %) | (6382 %) | - | - | - |
| Profit | (55.7m) | (71.5m) | (111m) | (45.6m) | (42.3m) | (44.6m) | - |
| % profit margin | (1154 %) | (198 %) | (2826 %) | (5176 %) | - | - | - |
| R&D budget | 48.6m | 89.6m | 98.3m | 36.4m | 16.1m | 31.2m | - |
| R&D % of revenue | 1008 % | 248 % | 2496 % | 4134 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Angel | ||
$1.5m | Series A | ||
$6.3m | Early VC | ||
$6.3m | Early VC | ||
| N/A | N/A | IPO | |
| N/A | $12.7m | Post IPO Equity | |
$5.0m | Grant | ||
* | $14.8m | Post IPO Equity | |
* | N/A | $27.2m | Post IPO Equity |
| N/A | $25.0m | Grant | |
* | N/A | $40.0m | Post IPO Equity |
* | N/A | $46.0m | Post IPO Equity |
* | $50.0m | Post IPO Debt | |
* | N/A | $94.5m | Post IPO Equity |
| Total Funding | CAD60.1m | ||
Recent News about Corbus Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.